Site Search

PROVIDENCE –Today, the Rhode Island Senate passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. Dubbed ‘the right treatment, to the right patient, at the right time,’ precision medicine has played a critical role in improving cancer outcomes – biomarker testing being one of the ways we can achieve these outcomes by allowing doctors to understand and target unique markers in a patient’s ...